DRD
CLLS

Dennis R. Delaney’s Cellectis CLLS Stock Holding History

Dennis R. Delaney’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.1K Hold
24,000
– – 0.03% 59
2025
Q4 		$116K Hold
24,000
– – 0.06% 47
2025
Q3 		$68.4K Buy
+24,000
New +$62.2K 0.03% 48

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dennis R. Delaney's CLLS Position: Q1 2026 in Review

Dennis R. Delaney held its Cellectis (CLLS) position steady in Q1 2026 at 24,000 shares worth $76.1K. The position accounts for 0.03% of the portfolio, ranked #59.

Dennis R. Delaney first reported a position in CLLS in Q3 2025 and has held it in 3 quarters since. The position peaked at $116K in Q4 2025. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

  • Dennis R. Delaney held 24,000 shares of Cellectis worth $76.1K as of Q1 2026.
  • Dennis R. Delaney left its Cellectis share count unchanged in Q1 2026.
  • Cellectis made up 0.03% of Dennis R. Delaney's portfolio in Q1 2026, its #59 holding.
  • Dennis R. Delaney first reported a position in Cellectis in Q3 2025 and has held it in 3 quarters since.
  • Dennis R. Delaney's Cellectis position peaked at $116K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Dennis R. Delaney's 13F filing for Q1 2026, filed 14 May 2026.